20
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Autologous stem cell transplantation in adults with atypical teratoid rhabdoid tumor: a case report and review

ORCID Icon, , , , , , & show all
Article: 2375960 | Received 26 Sep 2023, Accepted 12 Jun 2024, Published online: 23 Jul 2024

References

  • Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016;131(6):803–820. doi:10.1007/s00401-016-1545-1
  • Louis DN, Perry A, Wesseling P, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro-oncology. 2021;23(8):1231–1251. doi:10.1093/neuonc/noab106
  • Zin F, Cotter JA, Haberler C, et al. Histopathological patterns in atypical teratoid/rhabdoid tumors are related to molecular subgroup. Brain Pathol. 2021;31(5):e12967. doi:10.1111/bpa.12967
  • Kanoto M, Toyoguchi Y, Hosoya T, Kuchiki M, Sugai Y. Radiological image features of the atypical teratoid/rhabdoid tumor in adults: a systematic review. Clin Neuroradiol. 2015;25(1):55–60. doi:10.1007/s00062-013-0282-2
  • Broggi G, Gianno F, Shemy DT, et al. Atypical teratoid/rhabdoid tumor in adults: a systematic review of the literature with meta-analysis and additional reports of 4 cases. J Neurooncol. 2022;157(1):1–14. doi:10.1007/s11060-022-03959-z
  • Ostrom QT, Chen Y, M de Blank P, et al. The descriptive epidemiology of atypical teratoid/rhabdoid tumors in the United States, 2001–2010. Neuro-oncology. 2014;16(10):1392–1399. doi:10.1093/neuonc/nou090
  • Nicolaides T, Tihan T, Horn B, Biegel J, Prados M, Banerjee A. High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system. J Neurooncol. 2010;98(1):117–123. doi:10.1007/s11060-009-0071-6
  • Gidwani P, Levy A, Goodrich J, Weidenheim K, Kolb EA. Successful outcome with tandem myeloablative chemotherapy and autologous peripheral blood stem cell transplants in a patient with atypical teratoid/rhabdoid tumor of the central nervous system. J Neurooncol. 2008;88(2):211–215. doi:10.1007/s11060-008-9553-1
  • Paolini MA, Kipp BR, Sukov WR, et al. Sellar region atypical teratoid/rhabdoid tumors in adults: clinicopathological characterization of five cases and review of the literature. J Neuropathol Exp Neurol. 2018;77(12):1115–1121. doi:10.1093/jnen/nly091
  • Dardis C, Yeo J, Milton K, et al. Atypical teratoid rhabdoid tumor: two case reports and an analysis of adult cases with implications for pathophysiology and treatment. Front Neurol. 2017;8:247. doi:10.3389/fneur.2017.00247
  • Nobusawa S, Hirato J, Sugai T, et al. Atypical teratoid/rhabdoid tumor (AT/RT) arising from ependymoma: a type of AT/RT secondarily developing from other primary central nervous system tumors. J Neuropathol Exp Neurol. 2016;75(2):167–174. doi:10.1093/jnen/nlv017
  • De Amorim Bernstein K, Sethi R, Trofimov A, et al. Early clinical outcomes using proton radiation for children with central nervous system atypical teratoid rhabdoid tumors. Int J Radiat Oncol Biol Phys. 2013;86(1):114–120. doi:10.1016/j.ijrobp.2012.12.004
  • Hasselblatt M, Oyen F, Gesk S, et al. Cribriform neuroepithelial tumor (CRINET): a nonrhabdoid ventricular tumor with INI1 loss and relatively favorable prognosis. J Neuropathol Exp Neurol. 2009;68(12):1249–1255. doi:10.1097/NEN.0b013e3181c06a51
  • Gessi M, Japp AS, Dreschmann V, et al. High-resolution genomic analysis of cribriform neuroepithelial tumors of the central nervous system. J Neuropathol Exp Neurol. 2015;74(10):970–974. doi:10.1097/NEN.0000000000000239
  • Kleinschmidt-DeMasters BK, Alassiri AH, Birks DK, Newell KL, Moore W, Lillehei KO. Epithelioid versus rhabdoid glioblastomas are distinguished by monosomy 22 and immunohistochemical expression of INI-1 but not claudin 6. Am J Surg Pathol. 2010;34(3):341–354. doi:10.1097/PAS.0b013e3181ce107b
  • Bertrand A, Rondenet C, Masliah-Planchon J, et al. Rhabdoid component emerging as a subclonal evolution of paediatric glioneuronal tumours. Neuropathol Appl Neurobiol. 2018;44(2):224–228. doi:10.1111/nan.12379
  • Alva E, Rubens J, Chi S, et al. Recent progress and novel approaches to treating atypical teratoid rhabdoid tumor. Neoplasia (New York, N.Y.). 2023;37:100880. doi:10.1016/j.neo.2023.100880
  • Gardner SL, Asgharzadeh S, Green A, Horn B, McCowage G, Finlay J. Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors. Pediatric Blood Cancer. 2008;51(2):235–240. doi:10.1002/pbc.21578
  • Zaky W, Dhall G, Ji L, et al. Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experience. Pediatric Blood Cancer. 2014;61(1):95–101. doi:10.1002/pbc.24648
  • Reddy AT, Strother DR, Judkins AR, et al. Efficacy of high-dose chemotherapy and three-dimensional conformal radiation for atypical teratoid/rhabdoid tumor: a report from the Children's Oncology Group Trial ACNS0333. J Clin Oncol. 2020;38(11):1175–1185. doi:10.1200/JCO.19.01776
  • Upadhyaya SA, Robinson GW, Onar-Thomas A, et al. Relevance of molecular groups in children with newly diagnosed atypical teratoid rhabdoid tumor: results from prospective St. Jude multi-institutional trials. Clin Cancer Res. 2021;27(10):2879–2889. doi:10.1158/1078-0432.CCR-20-4731
  • National Cancer Institute. Atypical Teratoid Rhabdoid Tumor (ATRT) Diagnosis and Treatment. The Website of the National Cancer Institute. 2023. Retrieved September 4, 2023, from https://www.cancer.gov/rare-brain-spine-tumor/tumors/atrt